scholarly journals ON BACTERIOLOGICAL STUDY OF BONE-DEFECT TREATMENT TRANSPLANTING THE LOCAL BONE CHIPS IN SURGICAL PROCEDURES ON JAW BONE

1965 ◽  
Vol 18 (3.4) ◽  
pp. 173-186
Author(s):  
Minoru Kajiyama ◽  
Toshiyasn Uji
2021 ◽  
Vol 6 (11) ◽  
pp. 3659-3670
Author(s):  
Teng Zhang ◽  
Qingguang Wei ◽  
Hua Zhou ◽  
Zehao Jing ◽  
Xiaoguang Liu ◽  
...  

Injury ◽  
2018 ◽  
Vol 49 (3) ◽  
pp. 523-531 ◽  
Author(s):  
Magdalena Tarchala ◽  
Victor Engel ◽  
Jake Barralet ◽  
Edward J. Harvey

2004 ◽  
Vol 12 (1) ◽  
pp. 62-69 ◽  
Author(s):  
Lucele Vieira Marins ◽  
Tania Mary Cestari ◽  
André Dotto Sottovia ◽  
José Mauro Granjeiro ◽  
Rumio Taga

Over the last few years, various bone graft materials of bovine origin to be used in oromaxillofacial surgeries have entered the market. In the present study, we determined the capacity of a block organic bone graft material (Gen-ox, Baumer SA, Brazil) prepared from bovine cancellous bone to promote the repair of critical size bone injuries in rat calvaria. A transosseous defect measuring approximately 8mm in diameter was performed with a surgical trephine in the parietal bone of 25 rats. In 15 animals, the defects were filled with a block of graft material measuring 8mm in diameter and soaked in the animal's own blood, and in the other 10 animals the defects were only filled with blood clots. The calvariae of rats receiving the material were collected 1, 3 and 6 months after surgery, and those of animals receiving the blood clots were collected immediately and 6 months after surgery. During surgery, the graft material was found to be of easy handling and to adapt perfectly to the receptor bed after soaking in blood. The results showed that, in most animals treated, the material was slowly resorbed and served as a space filling and maintenance material, favoring angiogenesis, cell migration and adhesion, and bone neoformation from the borders of the lesion. However, a foreign body-type granulomatous reaction, with the presence of numerous giant cells preventing local bone neoformation, was observed in two animals of the 1-month subgroup and in one animal of the 3-month subgroup. These cases were interpreted as resulting from the absence of demineralization and the lack of removal of potential antigen factors during production of the biomaterial. We conclude that, with improvement in the quality control of the material production, block organic bone matrix will become a good alternative for bone defect repair in the oromaxillofacial region due to its high osteoconductive capacity.


2013 ◽  
Vol 22 (1) ◽  
pp. 175-187 ◽  
Author(s):  
Zhi-Yong Zhang ◽  
Ai-Wen Huang ◽  
Jun Jun Fan ◽  
Kuanhai Wei ◽  
Dan Jin ◽  
...  

Author(s):  
Stanislav Abulkhanov ◽  
Ivan Bairikov ◽  
Dmitriy Goryainov ◽  
Oleg Slesarev ◽  
Aleksey Bairikov

2018 ◽  
Vol 19 (9) ◽  
pp. 2526 ◽  
Author(s):  
Anna Rapp ◽  
Ronny Bindl ◽  
Annika Erbacher ◽  
Anne Kruchen ◽  
Markus Rojewski ◽  
...  

The application of autologous mesenchymal stem cells (MSC) for the treatment of bone defects requires two invasive procedures and several weeks of ex vivo cell expansion. To overcome these limitations, the administration of allogeneic MSC may be attractive, because they are anticipated to be immunoprivileged. Because preclinical studies using various animal models are conflicting with respect to the efficacy of allogeneic MSC, we investigated whether autologous and allogeneic human MSC (hMSC) are equally effective in regenerating bone in a humanized mouse model resembling the human immune system. Applying autologous and allogeneic hMSC in critically sized femoral defects, we found that allogeneic hMSC elicited a mild immune response early after implantation, whereas early angiogenic processes were similar in both treatments. At later healing time points, the transplantation of allogeneic hMSC resulted in less bone formation than autologous hMSC, associated with a reduced expression of the osteogenic factor Runx2 and impaired angiogenesis. We found by species-specific staining for collagen-type-1α2 that MSCs of either source did not synthesize new bone matrix, indicating an indirect contribution of transplanted hMSC to bone regeneration. In conclusion, our data suggest that the application of autologous hMSC is superior to that of allogeneic cells for bone defect treatment.


Sign in / Sign up

Export Citation Format

Share Document